Healthcare >> CEO Interviews >> February 27, 2002
KEMP COADY, III became an Executive Director of Deltex Medical Holdings Limited in September 1998 and was appointed Chief Executive Officer in October 1998. He has worked for more than 20 years in the medical device industry. Between 1982 and 1990 he held senior positions for Philips Medical Systems North America in its CT Scanning and X-ray Divisions. In 1990 he became Vice President of Sales and Marketing for ISG Technologies, an emerging medical device company which produced three-dimensional, imaging devices for surgical guidance and helped lead the company to a NASDAQ initial public offering in 1992. He became President and Chief Executive Officer of a start up haemodynamic monitoring company, MCG International, in 1992. State and venture capital financing was raised to fund the development of monitoring systems and consumable sound detection devices. MCG International was sold to the military contractor Harris Corporation in 1994. In the past four years he has been Head of World-wide Marketing and Business Development for Datascope's Patient Monitoring Division and Head of the Medical Devices Division of the contract research organisation, Quintiles. He is also a member of the board of Memry Corporation, a manufacturer of nitinol based medical components of Branford, CT. He has a BSc. in Chemistry and Biology from Bates College and an MBA from Cornell University. Profile
TWST: Could we begin with an historical sketch and overview of Deltex Medical?
Mr. Coady: Deltex, as the company is today, was formed back in late 80s, it was not in its current